Sigilon Therapeutics, Inc. Cash on Hand 2021-2023 | SGTX
Sigilon Therapeutics, Inc. cash on hand from 2021 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| Sigilon Therapeutics, Inc. Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2022 | $70 |
| 2021 | $124 |
| 2020 | $202 |
| 2019 | $76 |
| Sigilon Therapeutics, Inc. Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2023-06-30 | $35 |
| 2023-03-31 | $57 |
| 2022-12-31 | $70 |
| 2022-09-30 | $79 |
| 2022-06-30 | $89 |
| 2022-03-31 | $103 |
| 2021-12-31 | $124 |
| 2021-09-30 | $140 |
| 2021-06-30 | $162 |
| 2021-03-31 | $179 |
| 2020-12-31 | $202 |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
